ADAM15
Basic information
Region (hg38): 1:155050566-155062775
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (129 variants)
- not_provided (5 variants)
- EBV-positive_nodal_T-_and_NK-cell_lymphoma (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ADAM15 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000207197.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 117 | 127 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
Total | 0 | 0 | 118 | 14 | 1 |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ADAM15 | protein_coding | protein_coding | ENST00000356955 | 23 | 12211 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.44e-16 | 0.945 | 125629 | 0 | 119 | 125748 | 0.000473 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.07 | 433 | 500 | 0.865 | 0.0000290 | 5463 |
Missense in Polyphen | 156 | 192.72 | 0.80945 | 2233 | ||
Synonymous | 1.42 | 177 | 203 | 0.874 | 0.0000113 | 1831 |
Loss of Function | 2.35 | 33 | 51.1 | 0.646 | 0.00000298 | 501 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00115 | 0.00112 |
Ashkenazi Jewish | 0.000199 | 0.000198 |
East Asian | 0.00109 | 0.00103 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000440 | 0.000422 |
Middle Eastern | 0.00109 | 0.00103 |
South Asian | 0.000694 | 0.000686 |
Other | 0.000854 | 0.000815 |
dbNSFP
Source:
- Function
- FUNCTION: Active metalloproteinase with gelatinolytic and collagenolytic activity. Plays a role in the wound healing process. Mediates both heterotypic intraepithelial cell/T-cell interactions and homotypic T-cell aggregation. Inhibits beta-1 integrin-mediated cell adhesion and migration of airway smooth muscle cells. Suppresses cell motility on or towards fibronectin possibly by driving alpha-v/beta-1 integrin (ITAGV-ITGB1) cell surface expression via ERK1/2 inactivation. Cleaves E-cadherin in response to growth factor deprivation. Plays a role in glomerular cell migration. Plays a role in pathological neovascularization. May play a role in cartilage remodeling. May be proteolytically processed, during sperm epididymal maturation and the acrosome reaction. May play a role in sperm-egg binding through its disintegrin domain. {ECO:0000269|PubMed:12091380, ECO:0000269|PubMed:15358598, ECO:0000269|PubMed:15818704, ECO:0000269|PubMed:17416588, ECO:0000269|PubMed:17575078, ECO:0000269|PubMed:18387333, ECO:0000269|PubMed:18434311}.;
- Pathway
- Invadopodia formation;Extracellular matrix organization;Degradation of the extracellular matrix;Alpha9 beta1 integrin signaling events
(Consensus)
Recessive Scores
- pRec
- 0.138
Intolerance Scores
- loftool
- 0.987
- rvis_EVS
- -0.57
- rvis_percentile_EVS
- 19.01
Haploinsufficiency Scores
- pHI
- 0.104
- hipred
- Y
- hipred_score
- 0.678
- ghis
- 0.532
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.687
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Adam15
- Phenotype
- neoplasm; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); vision/eye phenotype;
Gene ontology
- Biological process
- angiogenesis;negative regulation of cell-matrix adhesion;immune response to tumor cell;proteolysis;apoptotic process;cell-matrix adhesion;integrin-mediated signaling pathway;male gonad development;extracellular matrix disassembly;extracellular matrix organization;negative regulation of cell growth;negative regulation of cell migration;collagen catabolic process;tissue regeneration;innate immune response;cardiac epithelial to mesenchymal transition;negative regulation of receptor binding;cellular response to phorbol 13-acetate 12-myristate;response to hypobaric hypoxia
- Cellular component
- acrosomal vesicle;plasma membrane;adherens junction;cell surface;integral component of membrane;motile cilium;extracellular exosome
- Molecular function
- metalloendopeptidase activity;integrin binding;protein binding;metallopeptidase activity;SH3 domain binding;metal ion binding